Skin Elements Limited (ASX:SKN) has applied to ASX for quotation of 337,272,727 ordinary fully paid shares issued on 9 November 2026, comprising a placement tranche and broker fee shares, following a proposed issue of securities previously notified to the market on 27 October 2026.

Key Points

  • 337,272,727 ordinary fully paid shares applied for quotation, with an issue date of 9 November 2026.
  • 318,181,818 shares issued for cash at AUD $0.0022 per share, held by one holder in the 100,001 and over category.
  • 19,090,909 shares issued as a broker fee equivalent to $42,000, representing 6% of gross funds raised.
  • Total quoted ordinary fully paid shares on issue will reach 3,846,606,842 following quotation.

Placement and Broker Fee Share Details

According to the filing, the 337,272,727 shares are split across two tranches. The first tranche of 318,181,818 ordinary fully paid shares was issued for cash consideration in Australian dollars at an issue price of AUD $0.0022 per share, with all shares held by a single holder in the 100,001 and over distribution category. The second tranche of 19,090,909 shares was issued as a non-cash broker fee, described as 6% of gross funds raised, equivalent to $42,000, also valued at $0.0022 per share. Both tranches carry an issue date of 9 November 2026.

Connection to Previously Disclosed Appendix 3B

The filing states that the securities being quoted were issued as part of a transaction previously announced to the market via an Appendix 3B lodged on 27 October 2026, titled "New – Proposed issue of securities – SKN." The transaction is classified as a placement or other type of issue. The filing confirms there are no further issues of securities yet to take place to complete the transaction referred to in that Appendix 3B, indicating the placement has been fully executed with the two tranches described in this quotation application.

Issued Capital Following Quotation

Following quotation of the new shares, the total number of ordinary fully paid shares on issue will be 3,846,606,842. The company also has unquoted securities on issue, comprising 100,000,000 Performance Shares Class A, 62,000,000 Performance Shares Class B, 347,500,000 options expiring 12 December 2028 at an exercise price of $0.006, 125,000,000 options expiring 12 December 2028 at an exercise price of $0.006 under a separate class, and 219,061,355 options expiring 21 February 2028 at an exercise price of $0.01, according to the filing.